New Waverly, TX, United States of America

Robert P Lenk


Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 62(Granted Patents)


Location History:

  • New Waverly, TX (US) (1993 - 1998)
  • Willis, TX (US) (1998)

Company Filing History:


Years Active: 1993-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Robert P. Lenk: A Focus on Cancer Treatment

Introduction

Robert P. Lenk, an innovative inventor based in New Waverly, Texas, has significantly contributed to the field of pharmaceuticals. With three patents to his name, he has demonstrated a commitment to developing methods and formulations that have the potential to improve cancer treatment.

Latest Patents

Among Robert's latest inventions is the patent for a "Liposomal-polyene preliposomal powder and method for its preparation." This method details a process for creating a stable preliposomal powder that, when mixed with water or saline solution, generates a suspension of liposomes containing polyene drugs like nystatin. The key steps involve the combination of phospholipids and organic solvents, along with a clarifying agent, to produce a clear solution from which organic solvents are then removed, yielding a powder.

Additionally, he holds a patent for the "Formulation and use of carotenoids in treatment of cancer," which introduces a reduced-toxicity formulation that remains stable in aqueous environments. This innovative formulation includes carotenoids, lipid carrier particles (such as liposomes), and an intercalation promoter agent like triglycerides. This method has shown efficacy in inhibiting the growth of cancer cells by administering a therapeutically effective amount of the described composition.

Career Highlights

Robert P. Lenk has made impactful strides in the pharmaceutical industry through his work at prestigious institutions, including the University of Texas System and Aronex Pharmaceuticals, Inc. His research and advancements in drug formulations reflect his dedication to enhancing therapeutic options for patients dealing with cancer.

Collaborations

Throughout his career, Robert has collaborated with notable professionals such as Gabriel Lopez-Berestein and Reeta Mehta. These partnerships highlight a shared commitment to advancing medical science and tackling the challenges associated with cancer treatment.

Conclusion

Robert P. Lenk's inventions are a testament to the potential of innovative thinking in the pharmaceutical industry. His latest patents pave the way for improved therapies, particularly in the realm of cancer treatment. As research continues to evolve, Robert's contributions remain crucial in the fight against this challenging disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…